NGL Fine-ChemNSE:NGLFINE +0.78%78 Quick Ratio is 1.37 as of Mar. 2026, which is 13% below its 10-year median of 1.57. GuruFocus rates NSE:NGLFINE with a GF Score™ of 78/100 and a GF Value™ of ₹2,836.47 (Fairly Valued). The stock has 8 warning signs investors should review. Among 994 Drug Manufacturers companies, NGL Fine-Chem ranks worse than 52.11% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. NGL Fine-Chem's quick ratio for the quarter that ended in Mar. 2026 was 1.37.
NGL Fine-Chem has a quick ratio of 1.37. It generally indicates good short-term financial strength.
The historical rank and industry rank for NGL Fine-Chem's Quick Ratio or its related term are showing as below:
NSE:NGLFINE'
s Quick Ratio Range Over the Past 10 Years
Min: 0.97 Med: 1.57 Max: 2.33
Current: 1.37
During the past 13 years, NGL Fine-Chem's highest Quick Ratio was 2.33. The lowest was 0.97. And the median was 1.57.
NSE:NGLFINE's Quick Ratio is ranked worse than 52.11% of 994
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs NSE:NGLFINE: 1.37
NGL Fine-Chem (NSE:NGLFINE) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
NGL Fine-Chem Quick Ratio Related Terms
NGL Fine-Chem Quick Ratio Historical Data
* Premium members only.
The historical data trend for NGL Fine-Chem's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:NGLFINE vs LLY, JNJ, ABBV: Quick Ratio Comparison
For the Drug Manufacturers - General subindustry, NGL Fine-Chem's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NGL Fine-Chem Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, NGL Fine-Chem's Quick Ratio distribution charts can be found below:
* The bar in red indicates where NGL Fine-Chem's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
NGL Fine-Chem's Quick Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGL Fine-Chem (NSE:NGLFINE) has a Quick Ratio of 1.37 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on NGL Fine-Chem and its competitors. This is 13% below median its historical median of 1.57. Over the past decade, NGL Fine-Chem's Quick Ratio has ranged from 0.97 to 2.33. According to the industry distribution chart, NGL Fine-Chem ranks #518 out of 994 companies in the Drug Manufacturers industry, placing it in the top 52.1%.
Is NGL Fine-Chem's Quick Ratio too high?
NGL Fine-Chem's current Quick Ratio of 1.37 is 13% below median its 10-year median of 1.57. Over the past 10 years, this metric has ranged from a low of 0.97 to a high of 2.33. The Drug Manufacturers industry median Quick Ratio is 1.45. NGL Fine-Chem's value of 1.37 is 5.5% below this industry median. Based on the distribution chart, NGL Fine-Chem ranks #518 out of 994 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, NGL Fine-Chem has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does NGL Fine-Chem's Quick Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, NGL Fine-Chem ranks #518 out of 994 companies for Quick Ratio. This places NGL Fine-Chem in the lower half of its industry. The industry median Quick Ratio is 1.45. NGL Fine-Chem's value of 1.37 is 5.5% below this benchmark. Historically, NGL Fine-Chem's own Quick Ratio has ranged from 0.97 to 2.33 over the past decade. While the company's 10-year median is 1.57 vs. the industry median of 1.45, NGL Fine-Chem has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 994 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NGL Fine-Chem's current Quick Ratio of 1.37 is 5.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on NGL Fine-Chem and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NGL Fine-Chem's current Quick Ratio is 1.37, which is 13% below median its own 10-year median of 1.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NGL Fine-Chem stock overvalued right now?
Based on GuruFocus' analysis, NGL Fine-Chem (NSE:NGLFINE) is currently considered Fairly Valued. The stock's GF Value™ is ₹2,836.47, compared to a current price of ₹3,107.50 — trading 9.6% above its estimated fair value. The current Quick Ratio is 1.37, which is 13% below median its 10-year median of 1.57 and 5.5% below the Drug Manufacturers industry median of 1.45. NGL Fine-Chem's overall GF Score™ is 78/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For NGL Fine-Chem (NSE:NGLFINE), the current Quick Ratio is 1.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NGL Fine-Chem (NSE:NGLFINE) Overvalued in 2026?
Based on GuruFocus' analysis, NGL Fine-Chem stock appears to be overvalued.
The current stock price of ₹3,107.50 is trading 9.6% above its estimated GF Value™ of ₹2,836.47.
GuruFocus considers NGL Fine-Chem to be Fairly Valued.
Key valuation signals for NSE:NGLFINE:
Quick Ratio: 1.37 (13% below median its 10-year median of 1.57)
GF Value™: ₹2,836.47 vs. price of ₹3,107.50 (9.6% above fair value)
Industry Position: 5.5% below the Drug Manufacturers median (#518 of 994)
No single metric tells the full story. See the NSE:NGLFINE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.
78GF Score
Get the complete analysis for NSE:NGLFINE
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NGLFINE has been successfully added to your 
